-
Product Insights
Myocarditis – Drugs In Development, 2023
Global Markets Direct’s, ‘Myocarditis - Drugs In Development, 2023’, provides an overview of the Myocarditis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocarditis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Spinal Muscular Atrophy (SMA) – Drugs In Development, 2023
Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Drugs In Development, 2023’, provides an overview of the Spinal Muscular Atrophy (SMA) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Spinal Muscular Atrophy (SMA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Streptococcal Pneumonia – Drugs In Development, 2023
Global Markets Direct’s, ‘Streptococcal Pneumonia - Drugs In Development, 2023’, provides an overview of the Streptococcal Pneumonia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Streptococcal Pneumonia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Huntington Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Huntington Disease - Drugs In Development, 2023’, provides an overview of the Huntington Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Huntington Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Transdermal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transdermal Drug Delivery Pipeline Market Report Overview Transdermal drug delivery devices are medicated adhesive patches placed on the skin to deliver a specific dose of medication through the skin into the bloodstream. The Transdermal Drug Delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Product Insights
Cardiac Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cardiac Assist Devices Pipeline Market Report Overview Cardiac assist devices are used to support the failing heart which cannot be managed with standard medical therapy. These devices can be used for both short-term and long-term purposes allowing the heart to rest long enough so that it can return to normal. The cardiac assist devices pipeline market research report provides comprehensive information about the cardiac assist devices pipeline products with a comparative analysis of the products at various stages of development...
-
Track & Monitor
Immuno-oncology in Pharmaceuticals: Alpha-cinnamide compositions for cancer
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Product Insights
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hepatic encephalopathy is a worsening of brain function that occurs when the liver is no longer able to remove toxic substances in the blood. Symptoms include disorientation, drowsiness or confusion, change in sleep patterns, slurred speech and agitation, excitement, or rarely occurring seizures. The predisposing factors include gastrointestinal bleeding, increased protein intake, renal dysfunction with azotemia, constipation, drugs, and hypoxia. The Hepatic encephalopathy drugs in development market report provides an overview of the Hepatic Encephalopathy pipeline landscape. The report provides...
-
Product Insights
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...
-
Sector Analysis
Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape
This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.